308 related articles for article (PubMed ID: 17627984)
1. Feeding microstructure in diet-induced obesity susceptible versus resistant rats: central effects of urocortin 2.
Cottone P; Sabino V; Nagy TR; Coscina DV; Zorrilla EP
J Physiol; 2007 Sep; 583(Pt 2):487-504. PubMed ID: 17627984
[TBL] [Abstract][Full Text] [Related]
2. Centrally administered urocortin 2 decreases gorging on high-fat diet in both diet-induced obesity-prone and -resistant rats.
Cottone P; Sabino V; Nagy TR; Coscina DV; Levin BE; Zorrilla EP
Int J Obes (Lond); 2013 Dec; 37(12):1515-23. PubMed ID: 23478425
[TBL] [Abstract][Full Text] [Related]
3. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP
Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
[TBL] [Abstract][Full Text] [Related]
4. Intracerebroventricular urocortin 3 counteracts central acyl ghrelin-induced hyperphagic and gastroprokinetic effects via CRF receptor 2 in rats.
Yeh C; Ting CH; Doong ML; Chi CW; Lee SD; Chen CY
Drug Des Devel Ther; 2016; 10():3281-3290. PubMed ID: 27757017
[TBL] [Abstract][Full Text] [Related]
5. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide.
Spina M; Merlo-Pich E; Chan RK; Basso AM; Rivier J; Vale W; Koob GF
Science; 1996 Sep; 273(5281):1561-4. PubMed ID: 8703220
[TBL] [Abstract][Full Text] [Related]
6. Participation of corticotropin-releasing factor type 2 receptors in the acute, chronic and withdrawal actions of nicotine associated with feeding behavior in rats.
Kamdi SP; Nakhate KT; Dandekar MP; Kokare DM; Subhedar NK
Appetite; 2009 Dec; 53(3):354-62. PubMed ID: 19635511
[TBL] [Abstract][Full Text] [Related]
7. Meal pattern analysis of diet-induced obesity in susceptible and resistant rats.
Farley C; Cook JA; Spar BD; Austin TM; Kowalski TJ
Obes Res; 2003 Jul; 11(7):845-51. PubMed ID: 12855753
[TBL] [Abstract][Full Text] [Related]
8. Reduced brain CRH and GR mRNA expression precedes obesity in juvenile rats bred for diet-induced obesity.
Michel C; Dunn-Meynell A; Levin BE
Behav Brain Res; 2004 Oct; 154(2):511-7. PubMed ID: 15313040
[TBL] [Abstract][Full Text] [Related]
9. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.
Zorrilla EP; Reinhardt LE; Valdez GR; Inoue K; Rivier JE; Vale WW; Koob GF
J Pharmacol Exp Ther; 2004 Sep; 310(3):1027-34. PubMed ID: 15115804
[TBL] [Abstract][Full Text] [Related]
10. Urocortins and cholecystokinin-8 act synergistically to increase satiation in lean but not obese mice: involvement of corticotropin-releasing factor receptor-2 pathway.
Gourcerol G; Wang L; Wang YH; Million M; Taché Y
Endocrinology; 2007 Dec; 148(12):6115-23. PubMed ID: 17932219
[TBL] [Abstract][Full Text] [Related]
11. Hypothalamic expression of urocortin 3 and the type 2 corticotropin-releasing factor receptor is regulated according to feeding state in lean but not obese Zucker rats.
Poulin AM; Lenglos C; Mitra A; Timofeeva E
Neuropharmacology; 2012 Jul; 63(1):147-53. PubMed ID: 22227020
[TBL] [Abstract][Full Text] [Related]
12. CRF and urocortin decreased brain stimulation reward in the rat: reversal by a CRF receptor antagonist.
Macey DJ; Koob GF; Markou A
Brain Res; 2000 Jun; 866(1-2):82-91. PubMed ID: 10825483
[TBL] [Abstract][Full Text] [Related]
13. Reduced anorexic effects of insulin in obesity-prone rats fed a moderate-fat diet.
Clegg DJ; Benoit SC; Reed JA; Woods SC; Dunn-Meynell A; Levin BE
Am J Physiol Regul Integr Comp Physiol; 2005 Apr; 288(4):R981-6. PubMed ID: 15604298
[TBL] [Abstract][Full Text] [Related]
14. Feeding response to melanocortin agonist predicts preference for and obesity from a high-fat diet.
Chandler PC; Viana JB; Oswald KD; Wauford PK; Boggiano MM
Physiol Behav; 2005 Jun; 85(2):221-30. PubMed ID: 15893778
[TBL] [Abstract][Full Text] [Related]
15. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists.
de Groote L; Peñalva RG; Flachskamm C; Reul JM; Linthorst AC
J Neurochem; 2005 Jul; 94(1):45-56. PubMed ID: 15953348
[TBL] [Abstract][Full Text] [Related]
16. Human urocortin II, a selective agonist for the type 2 corticotropin-releasing factor receptor, decreases feeding and drinking in the rat.
Inoue K; Valdez GR; Reyes TM; Reinhardt LE; Tabarin A; Rivier J; Vale WW; Sawchenko PE; Koob GF; Zorrilla EP
J Pharmacol Exp Ther; 2003 Apr; 305(1):385-93. PubMed ID: 12649393
[TBL] [Abstract][Full Text] [Related]
17. Urocortin, corticotropin releasing factor-2 receptors and energy balance.
Cullen MJ; Ling N; Foster AC; Pelleymounter MA
Endocrinology; 2001 Mar; 142(3):992-9. PubMed ID: 11181511
[TBL] [Abstract][Full Text] [Related]
18. Altered hypothalamic leptin, insulin, and melanocortin binding associated with moderate-fat diet and predisposition to obesity.
Irani BG; Dunn-Meynell AA; Levin BE
Endocrinology; 2007 Jan; 148(1):310-6. PubMed ID: 17023527
[TBL] [Abstract][Full Text] [Related]
19. Peptide YY containing enteroendocrine cells and peripheral tissue sensitivity to PYY and PYY(3-36) are maintained in diet-induced obese and diet-resistant rats.
Hyland NP; Pittman QJ; Sharkey KA
Peptides; 2007 Jun; 28(6):1185-90. PubMed ID: 17475366
[TBL] [Abstract][Full Text] [Related]
20. Sympathetic activity, age, sucrose preference, and diet-induced obesity.
Levin BE
Obes Res; 1993 Jul; 1(4):281-7. PubMed ID: 16353358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
